Titin-antisense RNA1 (TTN-AS1) has been regarded as a tumor-promoting lncRNA in numerous cancers, such as LUAD, hepatocellular carcinoma, cervical cancer, papillary thyroid cancer, and gastric cancer (12, 17–21). Here, TTN is linked to hepatocellular carcinoma.